Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Journal of Telemedicine and Telecare|June 13, 2023
Exploration on the development of public hospital-sponsored telemedicine platform: A case study in ChinaHuijie Qi, Yinqing Ying, Lili Zhu, et al.Frontiers in Pharmacology|September 10, 2024
In vitro mechanistic study on mycophenolate mofetil drug interactions: effect of prednisone, cyclosporine, and othersJunjun Mao, Feifei Yu, Weiwei Qin, et al.Patient Preference and Adherence|December 21, 2018
Validation of diabetes medication self-efficacy scale in Chinese with type 2 diabetesJiezhong Zheng, Yeli Wang, Xiangrong Ye, et al.Biomedical Chromatography : BMC|November 18, 2017
Determination of telbivudine in the plasma of chronic hepatitis B patients in long-term treatment by high-performance liquid chromatographic-tandem mass spectrometryBicui Chen, Li Chen, Cai Cheng, et al.European Journal of Clinical Pharmacology|September 15, 2018
FKBP1A rs6041749 polymorphism is associated with allograft function in renal transplant patientsZhuo Wu, Qinxia Xu, Xiaoyan Qiu, et al.Journal of Clinical Pharmacy and Therapeutics|October 19, 2022
Risk factors for high-dose methotrexate associated toxicities in patients with primary central nervous system lymphomaKai Sun, Hongwei Tao, Tianling Ding, et al.Journal of Pharmaceutical and Biomedical Analysis|August 14, 2016
Chemical profiling of San-Huang decoction by UPLC-ESI-Q-TOF-MSQingfeng Liu, Zheng Jiao, Yi Liu, et al.Frontiers in Pharmacology|November 17, 2022
Applying machine learning to the pharmacokinetic modeling of cyclosporine in adult renal transplant recipients: a multi-method comparisonJunjun Mao, Yuhao Chen, Luyang Xu, et al.International Immunopharmacology|June 22, 2024
A joint population pharmacokinetic model to assess the high variability of whole-blood and intracellular tacrolimus in early adult renal transplant recipientsJunjun Mao, Fang Zeng, Weiwei Qin, et al.Journal of Chemotherapy (Florence, Italy)|May 8, 2023
STAT3 and STAT6 polymorphisms predict the severity of adverse reactions in Chinese NSCLC patients receiving EGFR-TKIs therapyYan Wang, Huijie Qi, Tianxiao Wang, et al.Pageof 6